Advances in HbA1c Biosensor Development Based on Field Effect Transistors: A Review
Authors:
- 14 April 2020
- journal article
- review article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. PP (1530437X) , 1
Abstract
Diabetes mellitus is a lifelong disease and the 7th leading cause of death worldwide. Hyperglycemia is the major hallmark of this disease that causes many clinical complications. Therefore, to maintain blood glucose levels within a normal range in diabetic patients, regular monitoring is of crucial importance. Glycated hemoglobin (HbA1c) is a glucose-linked hemoglobin in blood representing the average glucose level over the past three months with the least effect of interfering factors. Thus, HbA1c can be used as an appropriate biomarker for screening, pre-diagnosis, and management of diabetes. Current methods for HbA1c level determination have certain drawbacks such as being complex, time-consuming, expensive and they require trained personnel. To overcome these drawbacks, recently developed bio-sensing systems have become a promising technology for HbA1c detection. Different types of biosensors are developed for HbA1c recognition including electrochemical, colorimetric, electro-chemiluminescent, and field-effect transistor (FET). FETs are based on the semiconductor nanostructures and have great potentials for label-free, sensitive, specific, and rapid diagnosis of HbA1c as point of care (POC) diagnostic devices. To improve the sensitive and selective detection of HbA1c in FET-based biosensors, lots of researches have focused on developing new methods for the immobilization of bio-recognition elements and designing nano-materials with unique features. To promote understanding of the evolution of HbA1c bio-sensing technologies over the last decades; we presented an overview of trends from complementary metal-oxide-semiconductor (CMOS) to FET-based nano-biosensors, with special emphasis on standardization of HbA1c assays, HbA1c biosensor overview, FETs overview, FETs principles for HbA1c detection and HbA1c marketing.Keywords
This publication has 82 references indexed in Scilit:
- Accuracy and Clinical Utility of a Point-of-Care HbA1c, Testing DevicePostgraduate Medicine, 2013
- Type 2 Diabetes Mellitus: A Review of Current TrendsOman Medical Journal, 2012
- High-sensitivity nanosensors for biomarker detectionChemical Society Reviews, 2011
- FET immunosensor for hemoglobin A1c using a gold nanofilm grown by a seed-mediated technique and covered with mixed self-assembled monolayersMicrochimica Acta, 2011
- Biosensor diagnosis of urinary tract infections: a path to better treatment?Trends in Pharmacological Sciences, 2011
- The Pros and Cons of Diagnosing Diabetes With A1CDiabetes Care, 2011
- A field effect transistor (FET)-based immunosensor for detection of HbA1c and HbBiomedical Microdevices, 2010
- Six of Eight Hemoglobin A1c Point-of-Care Instruments Do Not Meet the General Accepted Analytical Performance CriteriaClinical Chemistry, 2010
- Ion-Sensitive Field-Effect Transistor for Biological SensingSensors, 2009
- Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1cBlood, 2008